Morgan Stanley bitcoin ETF net inflow surpassed WisdomTree after 6 days of listing
Morgan Stanley Spot Bitcoin ETF (MSBT) has surpassed the cumulative net inflow of a certain exchange-traded fund (WBTC) listed since January 2024 after only 6 trading days on the market.
On Wednesday, MSBT saw a single-day inflow of 19.3 million US dollars, with total net inflow reaching 103 million US dollars, exceeding WBTC's 86 million US dollars. MSBT was listed on April 8 with the lowest market fee of 0.14%. If this momentum continues, it is expected to catch up with a certain exchange ETF (245 million US dollars), another exchange ETF (326 million US dollars), and yet another exchange ETF (375 million US dollars).
Currently, the spot Bitcoin ETF market is led by a certain exchange with 6.43 billion US dollars in net inflow, followed by another exchange with 1.09 billion US dollars. In addition, on Tuesday, Goldman Sachs submitted an application to the SEC to launch its own Bitcoin-linked ETF, indicating that more asset management companies are accelerating their entry into the Bitcoin ETF market.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.
TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).
Crypto prices
More
